A healthcare provider may prescribe abiraterone acetate (Zytiga™) to treat advanced prostate cancer that has spread to other parts of the body and has not responded to other medical treatments.
Available in the form of a tablet, abiraterone is taken once daily. It works by decreasing the amount of testosterone produced in the adrenal glands and in the prostate cancer cells. Testosterone stimulates the growth of prostate cancer cells. By lowering testosterone levels, abiraterone helps to slow down the growth of cancer cells.
Although most people tolerate abiraterone well, side effects may occur and can include muscle aches, joint swelling, and hot flushes.
(For more information on abiraterone acetate, click Abiraterone. This full-length article takes a closer look at this prescription medicine, including dosing guidelines and general safety precautions to be aware of before beginning treatment.)